Bennett GH, Carpenter L, Hao W, Song P, Steinberg J, Baptist AP Risk factors and clinical outcomes associated with fixed airflow obstruction in older adults with asthma. Ann Allergy Asthma Immunol. 2018 Feb;120(2):164-168.e1. doi: 10.1016/j.anai.2017.10.
Carr TF, Zeki AA, Kraft M Eosinophilic and Noneosinophilic Asthma. Am J Respir Crit Care Med. 2018 Jan 1;197(1):22-37. doi: 10.1164/rccm.201611-2232PP. No abstract available.
Fitzpatrick AM, Moore WC Severe Asthma Phenotypes - How Should They Guide Evaluation and Treatment? J Allergy Clin Immunol Pract. 2017 Jul-Aug;5(4):901-908. doi: 10.1016/j.jaip.2017.05.015.
Galant SP, Komarow HD, Shin HW, Siddiqui S, Lipworth BJ The case for impulse oscillometry in the management of asthma in children and adults. Ann Allergy Asthma Immunol. 2017 Jun;118(6):664-671. doi: 10.1016/j.anai.2017.04.009.
Kuo CW, Liao XM, Huang YC, Chang HY, Shieh CC Bronchoscopy-guided bronchial epithelium sampling as a tool for selecting the optimal biologic treatment in a patient with severe asthma: a case report. Allergy Asthma Clin Immunol. 2019 Nov 27;15:76. doi: 10
Li Y, Wang W, Lv Z, Li Y, Chen Y, Huang K, Corrigan CJ, Ying S Elevated Expression of IL-33 and TSLP in the Airways of Human Asthmatics In Vivo: A Potential Biomarker of Severe Refractory Disease. J Immunol. 2018 Apr 1;200(7):2253-2262. doi: 10.4049/jimm
Maneechotesuwan K Role of microRNA in severe asthma. Respir Investig. 2019 Jan;57(1):9-19. doi: 10.1016/j.resinv.2018.10.005. Epub 2018 Nov 16.
Parulekar AD, Diamant Z, Hanania NA Role of biologics targeting type 2 airway inflammation in asthma: what have we learned so far? Curr Opin Pulm Med. 2017 Jan;23(1):3-11. doi: 10.1097/MCP.0000000000000343.
Rasmussen F, Taylor DR, Flannery EM, Cowan JO, Greene JM, Herbison GP, Sears MR Risk factors for airway remodeling in asthma manifested by a low postbronchodilator FEV1/vital capacity ratio: a longitudinal population study from childhood to adulthood. Am J Respir Crit Care Med. 2002 Jun 1;165(11):1480-8. doi: 10.1164/rccm.2108009.
Specjalski K, Niedoszytko M MicroRNAs: future biomarkers and targets of therapy in asthma? Curr Opin Pulm Med. 2020 May;26(3):285-292. doi: 10.1097/MCP.0000000000000673.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
